About HBM Holdings Limited (HBMHF) — Dividend Analysis 2026
HBM Holdings Limited, a clinical-stage biopharmaceutical company, engages in the discovery and development of differentiated antibody therapeutics in immunology and oncology disease areas. It is developing Batoclimab (HBM9161), a human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor; Tanfanercept (HBM9036) to treat moderate to-severe dry eye disease; HBM7008, a bispecific antibody targeting tumor Associated antigen; and HBM4003, a human anti-CTLA-4 antibody against cytotoxic T-lymphocyte-associated antigen-4. The company is also developing HBM9022 for the treatment of SARS-COV-2; HBM9302 for the treatment of breast and gastric cancers; HBM7020 for the treatment of multiple myeloma; and HBM1007, HBM1029, HBM7015, HBM7008, and HBM1022 for the treatment of solid tumors. It operates in Mainland China, the United States, Europe, and internationally. The company has collaboration on antibody-drug conjugate projects with LegoChem Biosciences Inc. and Duality Biotherapeutics, Inc. HBM Holdings Limited was incorporated in 2016 and is based in Shanghai, the People's Republic of China.
Is HBMHF a good dividend investment in 2026?
HBMHF offers a 128.21% forward yield with a 50% payout ratio. Strand Safety Score: 45/100 (Moderate Risk). The 5-year dividend CAGR of 0% is modest — investors should weigh current income against growth alternatives.
HBMHF DRIP calculator — what's the difference?
With DRIP on a $10,000 investment over 10 years, your HBMHF portfolio grows to $30.06M vs $10.37M without reinvestment. This is the compound interest effect in action.
HBMHF dividend growth history & forecast
HBMHF has grown its dividend by 0% over the last year and 0% annually over 5 years. At this pace, an investor who holds for 10+ years will see their yield on cost grow substantially above the current 128.21%.
FCF ($30M) is below dividends paid ($1.7B) — risk of cut (FCF: $30M · Dividends est.: $1.7B)
Debt Leverage0.0× Debt/EBITDA
30 / 30 pts
30/30
Debt/EBITDA 0.0× — low leverage, balance sheet is strong
Earnings Momentum+0.0B → +0.0B → -0.1B
15 / 30 pts
15/30
Net income grew in the latest year — positive but trend is unconfirmed
OVERALL ASSESSMENT
Dividend at moderate risk — monitor coverage and debt closely.
STRAND SCORE
45
/100
Strand Safety Score™ is proprietary to DividendFlow. Inputs: FCF, Debt/EBITDA, Net Income from SEC filings via FMP. Not financial advice. N/A for ETFs, pre-revenue companies, and tickers without income statements.
🌍 HBMHF Yield by Country & Account Type
Real after-tax yield depends on where you live and how you hold HBMHF.
Gross yield
128.21%
Tax rate
15.00%
After-tax yield
108.98%
Real yield (−CPI)
106.18%
Account/Country
Tax Rate
After-tax Yield
Real Yield
$10K Annual Income
🇺🇸 Roth IRA / 401k
0%
128.21%
125.41%
$12,821 / yr
🇺🇸 US Taxable (15%) ✓
15%
108.98%
106.18%
$10,898 / yr
🇺🇸 US Taxable (20%)
20%
102.57%
99.77%
$10,257 / yr
🇬🇧 UK ISA
0%
128.21%
125.41%
$12,821 / yr
🇬🇧 UK Taxable
8.75%
116.99%
114.19%
$11,699 / yr
🇨🇦 TFSA
0%
128.21%
125.41%
$12,821 / yr
🇨🇦 CA Taxable
25%
96.16%
93.36%
$9,616 / yr
🇦🇺 Super (pension)
15%
108.98%
106.18%
$10,898 / yr
🇦🇺 AU Taxable
30%
89.75%
86.95%
$8,975 / yr
🇩🇪 DE Taxable
26.375%
94.39%
91.59%
$9,439 / yr
🇫🇷 FR Taxable
30%
89.75%
86.95%
$8,975 / yr
Real yield = after-tax yield minus US CPI of 2.8%. 12-month CPI (US BLS via FMP economic-indicators). Click any row to select. US withholding tax (30%, reducible by treaty) applies to non-US residents holding US stocks in taxable accounts.
🎯 HBMHF Income Goal & Break-Even
Dividend Break-Even
1yr
Years for dividends to fully repay your HBMHF investment of $1.56/share (🇺🇸 US Taxable (15%) · 15.00% tax)
$10K invested · 10 Years
Dividends earned (DRIP)
$236.7K
Lost to inflation (2.8% CPI)
−$2.5K
Real purchasing power gain
$234.3K
12-month CPI (US BLS via FMP economic-indicators).
How much do I need to invest in HBMHF for:
Shares needed
14,118
Capital required
$22,024
Monthly income
$2,000
Based on current dividend of $2.00/share/yr · 🇺🇸 US Taxable (15%) · static projection (no growth assumed).
📅 HBMHF Dividend Payment Schedule
HBMHF pays quarterly — 4 times per year. Next ex-div: TBD.
Jan
Feb
Mar
💰
Apr
May
Jun
💰
Jul
Aug
Sep
💰
Oct
Nov
Dec
💰
10 shares
$4.25 / payment
$17.00 / year after tax
100 shares
$42.50 / payment
$170.00 / year after tax
1,000 shares
$425.00 / payment
$1700.00 / year after tax
📊 HBMHF vs Healthcare Benchmarks
How HBMHF compares to typical Healthcare averages.
Benchmark: Healthcare
Dividend Yield▲+125.41% vs sectorBetter
HBMHF
128.21%
avg
2.80%
5Y Dividend CAGR▼-6.80% vs sectorBelow avg
HBMHF
0.00%
avg
6.80%
Payout Ratio▲-5.00% vs sectorBetter
HBMHF
50.00%
avg
55.00%
Benchmarks: S&P 500 sector averages (2024–2026). Sources: Morningstar, Bloomberg, NAREIT. 5Y CAGR for HBMHF sourced from FMP /financial-growth endpoint — real data, not estimates.
🏛️ HBMHF Insider Activity
No recent SEC filings reported in the last 90 days.
📊 About This Data
Dividend yields, payout ratios, and financial metrics are sourced from Financial Modeling Prep (FMP) and cross-referenced with SEC EDGAR filings. Data is cached and updated every 24 hours via our nightly refresh. DRIP projections are forward-looking estimates, not guarantees.
Educational purposes only. Not financial advice. DividendFlow is not a registered investment advisor. Projections generated by the HBMHF dividend calculator are estimates based on historical data and user inputs. Actual future returns, stock prices, and dividend payments will vary. Dividends can be cut or suspended at any time. All investments carry risk, including the loss of principal. Please consult a qualified financial professional before making any investment decisions. Full disclaimer →